| Literature DB >> 16531015 |
V P Kontaxakis1, B J Havaki-Kontaxaki, P P Ferentinos, K G Paplos, C R Soldatos.
Abstract
The objective of this study was to assess switching to amisulpride (AMS) in treatment-resistant schizophrenia. Seven male subjects were switched to AMS and followed for 8 weeks. PANSS scores improved from 123 to 66 over this period. We conclude that AMS is of interest in the treatment of refractory schizophrenia.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16531015 DOI： 10.1016/j.eurpsy.2006.01.013
Source DB: PubMed Journal: Eur Psychiatry ISSN： 0924-9338 Impact factor: 5.361